Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

OTC Medicines Play Central Role in How Americans Manage Health, New Study Finds


News provided by

Consumer Healthcare Products Association

Feb 18, 2026, 15:23 ET

Share this article

Share toX

Share this article

Share toX

National Survey of 21,000 Adults Captures Seven-Day Snapshot of Medication Use; OTC and Prescription Medicines Used in Tandem to Address Distinct Health Needs

WASHINGTON, Feb. 18, 2026 /PRNewswire/ -- A new, nationally-representative study published in the peer-reviewed medical journal JAMA Network Open provides a detailed picture of U.S. adults' use of over-the-counter (OTC) and prescription (Rx) medications. The study finds that nearly two-thirds (62%) of U.S. adults — approximately 166.5 million people — reported using at least one medication in the past seven days. Notably, 46% of those surveyed reported the use of an OTC medication during that same period, often to address everyday, self-treatable healthcare. 

Continue Reading
Medication use among U.S. adults in the previous seven days. Based on a nationally representative survey of 21,000 adults, responses were statistically weighted to reflect the U.S. adult population.
Medication use among U.S. adults in the previous seven days. Based on a nationally representative survey of 21,000 adults, responses were statistically weighted to reflect the U.S. adult population.

Rather than focusing on prescriptions written or medications taken at any point during an individual's lifetime, the study, Prevalence of Over-the-Counter and Prescription Medication Use in the US (Green et al, 2026), captures a snapshot of recent, self-reported use. Within a seven-day period, OTC and prescription medicines were reported at nearly identical rates, reflecting the co-use of different types of medicines within the same week to address distinct health needs.

"These findings show that OTC medicines are an important part of everyday health management for millions of Americans," said CHPA President and CEO Scott Melville. "As policymakers consider new approaches to improve the accessibility and affordability of healthcare, it's important to recognize the vital role OTC medicines already play in helping Americans manage healthcare needs. And supporting that role through sound policy, regulatory rigor, and public education remains a CHPA priority."

"Usually, medication evidence comes from prescriptions dispensed by pharmacies or products sold," said Jody Green Ph.D., principal investigator of the study, "but in this study we focused on what people actually used in the past seven days, which provides a clearer picture of how American adults manage their health conditions in daily life."

What the Study Measured

Adults often manage multiple health concerns at once, using more than one medication during a given week. The study evaluated recent, self-reported use of OTC and prescription medications across a range of common conditions, including both single-ingredient and fixed-dose combination products.

No information was collected on the care settings in which medications were taken or on health outcomes. The findings reflect how U.S. adults report managing their individual health needs through the use of both OTC and prescription medications. Prescription medications are commonly used for more serious or longer-term conditions, while OTC medicines are frequently used to manage short-term and everyday ailments.

What Americans Use Most

The published study identified the most commonly used Rx and OTC medicines reported by U.S. adults in the past seven days. The list includes familiar OTC products alongside widely used prescription medicines for chronic conditions, reflecting the mix of self-care and clinician-directed treatments people report using in everyday life. This mix underscores an important reality: healthcare is not an either-or proposition. It is a continuum in which consumers responsibly combine self-care and clinician-guided treatments to meet their needs.

"It's also notable that several of the most commonly used OTCs on the list were once only available by prescription," continued Melville. "Over the years, OTC medications — like naproxen, omeprazole, cetirizine, and loratadine to name a few — went through FDA's Rx-to-OTC switch process to change their status from prescription-only access to OTC. Their appearance on the list among the most commonly-used medicines is a great example of how smart regulatory changes can expand consumer access to safe and effective treatments for better self-care."

Notably, the four most commonly used medicines overall — acetaminophen, ibuprofen, aspirin, and naproxen — are all available over the counter, with the top three unchanged from patterns observed in national medication use surveys conducted approximately 25 years ago. The top 20 most commonly used medications include:

Rank

Medication

Total
N=21,000 (%)

Male
n=9,829 (%)

Female
n=11,171 (%)

1

Acetaminophen

6184 (29.4)

2452 (24.9)

3732 (33.4)

2

Ibuprofen

4693 (22.3)

1889 (19.2)

2804 (25.1)

3

Aspirin

3323 (15.8)

1705 (17.3)

1618 (14.5)

4

Naproxen

1454 (6.9)

652 (6.6)

802 (7.2)

5

Atorvastatin

1342 (6.4)

745 (7.6)

597 (5.3)

6

Lisinopril

1163 (5.5)

633 (6.4)

530 (4.7)

7

Levothyroxine

1086 (5.2)

251 (2.6)

835 (7.5)

8

Diphenhydramine

1082 (5.2)

399 (4.1)

683 (6.1)

9

Omeprazole

969 (4.6)

432 (4.4)

537 (4.8)

10

Amlodipine

965 (4.6)

487 (5.0)

478 (4.3)

11

Metformin

934 (4.4)

501 (5.1)

433 (3.9)

12

Caffeine

928 (4.4)

364 (3.7)

564 (5.0)

13

Cetirizine

833 (4.0)

319 (3.2)

514 (4.6)

14

Hydrochlorothiazide

828 (3.9)

367 (3.7)

461 (4.1)

15

Losartan

813 (3.9)

378 (3.8)

435 (3.9)

16

Metoprolol

756 (3.6)

369 (3.8)

387 (3.5)

17

Loratadine

606 (2.9)

237 (2.4)

369 (3.3)

18

Rosuvastatin

542 (2.6)

273 (2.8)

269 (2.4)

19

Fluticasone

534 (2.5)

216 (2.2)

318 (2.8)

20

Sertraline

524 (2.5)

156 (1.6)

368 (3.3)

Source: Green, et al (2026), Table 3

OTC Medicines in Everyday Use

One of the key findings of the study is the extent to which OTC medicines are used for self-treatable health concerns. Overall, six of the 10 most commonly used medicines identified in this study are available, or primarily available, as an OTC medication.

OTCs, Self-Care, and Health Policy

These findings provide updated, real-world context on how Americans use both Rx and OTC medicines as part of everyday health management. By documenting recent medication use rather than prescriptions written or products sold, the study offers relevant data to inform ongoing discussions about self-care, access, and the appropriate role of nonprescription medicines within the broader healthcare landscape.

Study Methods

Researchers conducted a large, nationally representative survey of U.S. adults, asking participants to report all prescription and OTC medicines they had used in the previous seven days. Responses were statistically weighted to reflect the U.S. adult population. By focusing on recent use rather than prescriptions written or lifetime recall, the study captures actual medication use within a defined, seven-day reporting period.

  • Sample size: 21,000 U.S. adults
  • Timeframe: June 2023 through April 2024
  • Recall window: Past seven days

Additional study details, including full methodology and detailed findings, are available in this fact sheet. See the full article here.

The Consumer Healthcare Products Association (CHPA), founded in 1881, is the national trade association representing the leading manufacturers and marketers of consumer healthcare products, including over-the-counter (OTC) medicines, dietary supplements, and OTC medical devices. CHPA is committed to empowering self-care by ensuring that Americans have access to products they can count on to be reliable, affordable, and convenient, while also delivering new and better ways to get and stay healthy. Visit www.chpa.org

SOURCE Consumer Healthcare Products Association

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Health Advocates Team-Up with #WearSunscreen Campaign to Spread the Word About Sun Safety

Health Advocates Team-Up with #WearSunscreen Campaign to Spread the Word About Sun Safety

On April 7, World Health Day, the Personal Care Products Council (PCPC) launched the #WearSunscreen campaign, a nationwide effort urging the public...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Pharmaceuticals

Pharmaceuticals

Medical Pharmaceuticals

Medical Pharmaceuticals

Surveys, Polls and Research

Surveys, Polls and Research

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.